<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04600232</url>
  </required_header>
  <id_info>
    <org_study_id>TB-LAM</org_study_id>
    <nct_id>NCT04600232</nct_id>
  </id_info>
  <brief_title>TB-LAM in the Diagnosis of TB</brief_title>
  <official_title>Clinical Utility of TB-LAM in the Diagnosis of Active TB in Hospitalized HIV-infected Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Public Health Clinical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Public Health Clinical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tuberculosis (TB) is still the leading cause of death in HIV-infected patients. Early&#xD;
      diagnosis of TB substantially improves the survival of HIV-infected patients. Urine based&#xD;
      detection of lipoarabinomannan (LAM) provides promising methods for quick diagnosis of TB in&#xD;
      HIV-infected patients. However, the sensitivity and specificity of TB-LAM is still not well&#xD;
      established, especially in area where non-tuberculosis mycobacterium is also prevalence. Here&#xD;
      we aimed to evaluate the clinical utility of TB-LAM in diagnosis of active TB in hospitalized&#xD;
      HIV-infected patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity against microbiological reference standard</measure>
    <time_frame>2 months</time_frame>
    <description>Number of TB-LAM positive/Number of positive by culture or Gene Xpert</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity against microbiological reference standard</measure>
    <time_frame>2 months</time_frame>
    <description>1-Number of TB-LAM negative/Number of negative by culture or Gene Xpert or smear</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity against composite reference standard</measure>
    <time_frame>2 months</time_frame>
    <description>Number of TB-LAM positive/Number of active TB diagnosed clinically</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity against composite reference standard</measure>
    <time_frame>2 months</time_frame>
    <description>1-Number of TB-LAM negative/Number of TB excluded</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>HIV Infections</condition>
  <condition>Tuberculosis</condition>
  <condition>Non-Tuberculous Mycobacterial Pneumonia</condition>
  <arm_group>
    <arm_group_label>Diagnosis arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Urine TB-LAM, sputum smear, Gene Xpert, mycobacterial culture</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Alere TB-LAM</intervention_name>
    <description>Subjects also undergo clinical evaluation including CT, sputum smear, Gene Xpert and mycobacterial culture.</description>
    <arm_group_label>Diagnosis arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hospitalized HIV-infected patients.&#xD;
&#xD;
          -  Willing to participate into the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Already diagnosed with active TB&#xD;
&#xD;
          -  Received any anti-tuberculosis drugs and/or quinolone for more than 7 days.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jun Chen, M.D</last_name>
    <phone>+86-21-37990333</phone>
    <phone_ext>3222</phone_ext>
    <email>qtchenjun@163.com</email>
  </overall_contact>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 20, 2020</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2020</study_first_posted>
  <last_update_submitted>October 20, 2020</last_update_submitted>
  <last_update_submitted_qc>October 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Public Health Clinical Center</investigator_affiliation>
    <investigator_full_name>Jun Chen</investigator_full_name>
    <investigator_title>Shanghai Public Health Clinical Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Participant data without individual identification can be provided upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

